191 related articles for article (PubMed ID: 7809953)
1. Dopamine receptor agonists, partial agonists and psychostimulant addiction.
Pulvirenti L; Koob GF
Trends Pharmacol Sci; 1994 Oct; 15(10):374-9. PubMed ID: 7809953
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor partial agonists and addiction.
Moreira FA; Dalley JW
Eur J Pharmacol; 2015 Apr; 752():112-5. PubMed ID: 25724788
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine for cocaine dependence. A controlled clinical trial.
Handelsman L; Rosenblum A; Palij M; Magura S; Foote J; Lovejoy M; Stimmel B
Am J Addict; 1997; 6(1):54-64. PubMed ID: 9097872
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological approaches to cocaine addiction.
Dackis CA; Gold MS
J Subst Abuse Treat; 1985; 2(3):139-45. PubMed ID: 3912517
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine treatment for cocaine abuse: the dopamine depletion hypothesis.
Dackis CA; Gold MS; Davies RK; Sweeney DR
Int J Psychiatry Med; 1985-1986; 15(2):125-35. PubMed ID: 3902694
[TBL] [Abstract][Full Text] [Related]
6. The potential of dopamine agonists in drug addiction.
Kosten TR; George TP; Kosten TA
Expert Opin Investig Drugs; 2002 Apr; 11(4):491-9. PubMed ID: 11922858
[TBL] [Abstract][Full Text] [Related]
7. Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.
Xi ZX; Gardner EL
Curr Drug Abuse Rev; 2008 Nov; 1(3):303-27. PubMed ID: 19430578
[TBL] [Abstract][Full Text] [Related]
8. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.
Rothman RB; Glowa JR
Mol Neurobiol; 1995; 11(1-3):1-19. PubMed ID: 8561954
[TBL] [Abstract][Full Text] [Related]
9. Daily cocaine use patterns: effects of contextual and psychological variables.
Palij M; Rosenblum A; Magura S; Handelsman L; Stimmel B
J Addict Dis; 1996; 15(4):13-37. PubMed ID: 8943580
[TBL] [Abstract][Full Text] [Related]
10. Lisuride reduces intravenous cocaine self-administration in rats.
Pulvirenti L; Koob GF
Pharmacol Biochem Behav; 1994 Apr; 47(4):819-22. PubMed ID: 8029249
[TBL] [Abstract][Full Text] [Related]
11. [Dopamine agonist in the treatment of Parkinson's disease].
Kuran W
Neurol Neurochir Pol; 1997; 31(3):545-54. PubMed ID: 9446045
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine-desipramine protocol in treatment of cocaine addiction.
Giannini AJ; Billett W
J Clin Pharmacol; 1987 Aug; 27(8):549-54. PubMed ID: 3308977
[TBL] [Abstract][Full Text] [Related]
13. Dopamine agonists for the treatment of cocaine dependence.
Amato L; Minozzi S; Pani PP; Solimini R; Vecchi S; Zuccaro P; Davoli M
Cochrane Database Syst Rev; 2011 Dec; (12):CD003352. PubMed ID: 22161376
[TBL] [Abstract][Full Text] [Related]
14. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
[TBL] [Abstract][Full Text] [Related]
15. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings.
Cousins MS; Roberts DC; de Wit H
Drug Alcohol Depend; 2002 Feb; 65(3):209-20. PubMed ID: 11841892
[TBL] [Abstract][Full Text] [Related]
16. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
Blum K; Gold MS
Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
[TBL] [Abstract][Full Text] [Related]
17. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine.
Svetlov SI; Kobeissy FH; Gold MS
J Addict Dis; 2007; 26(4):1-6. PubMed ID: 18032226
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of indirect dopamine agonists for psychostimulant dependence: a systematic review and meta-analysis of randomized controlled trials.
Pérez-Mañá C; Castells X; Vidal X; Casas M; Capellà D
J Subst Abuse Treat; 2011 Mar; 40(2):109-22. PubMed ID: 21036508
[TBL] [Abstract][Full Text] [Related]
19. Cocaine abuse and adult attention deficit disorder.
Cocores JA; Davies RK; Mueller PS; Gold MS
J Clin Psychiatry; 1987 Sep; 48(9):376-7. PubMed ID: 3624209
[TBL] [Abstract][Full Text] [Related]
20. [Bromocriptine: uses until now and prospects of new therapeutic applications].
Górska D
Neurol Neurochir Pol; 2000; 34(3):573-8. PubMed ID: 10979549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
